메뉴 건너뛰기




Volumn 23, Issue 25, 2005, Pages 5875-5877

Self-recognition and tumor response to immunotherapy

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 100; INTERLEUKIN 2; IPILIMUMAB; MELANOMA ANTIGEN; TUMOR VACCINE; CANCER VACCINE; TUMOR ANTIGEN;

EID: 24944449579     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.95.029     Document Type: Editorial
Times cited : (7)

References (14)
  • 1
    • 0032824973 scopus 로고    scopus 로고
    • Signaling defects in T lymphocytes of patients with malignancy
    • Whiteside TL: Signaling defects in T lymphocytes of patients with malignancy. Cancer Immunol Immunother 48:346-352, 1999
    • (1999) Cancer Immunol Immunother , vol.48 , pp. 346-352
    • Whiteside, T.L.1
  • 2
    • 0031722032 scopus 로고    scopus 로고
    • Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: Clinical relevance and effects of cytokine therapy
    • Bukowski RM, Rayman P, Uzzo R, et al: Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: Clinical relevance and effects of cytokine therapy. Clin Cancer Res 4:2337-2347, 1998
    • (1998) Clin Cancer Res , vol.4 , pp. 2337-2347
    • Bukowski, R.M.1    Rayman, P.2    Uzzo, R.3
  • 3
    • 0033514923 scopus 로고    scopus 로고
    • Immune surveillance against a solid tumor fails because of immunological ignorance
    • Ochsenbein AF, Klenerman P, Karrer U, et al: Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci U S A 96:2233-2238, 1999
    • (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 2233-2238
    • Ochsenbein, A.F.1    Klenerman, P.2    Karrer, U.3
  • 4
    • 0037460116 scopus 로고    scopus 로고
    • Recognition of pathogen-associated molecular patterns by TLR family
    • Akira S, Hemmi H: Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85:85-95, 2003
    • (2003) Immunol Lett , vol.85 , pp. 85-95
    • Akira, S.1    Hemmi, H.2
  • 5
    • 1642362512 scopus 로고    scopus 로고
    • Combined TLR and CD40 triggering induces potent CD8+ T-cell expansion with variable dependence on type I IFN
    • Ahonen CL, Doxsee CL, McGurran SM, et al: Combined TLR and CD40 triggering induces potent CD8+ T-cell expansion with variable dependence on type I IFN. J Exp Med 199:775-784, 2004
    • (2004) J Exp Med , vol.199 , pp. 775-784
    • Ahonen, C.L.1    Doxsee, C.L.2    McGurran, S.M.3
  • 6
    • 0028311276 scopus 로고
    • Combination cytokine therapy in cancer
    • Goldfarb RH, Whiteside TL eds, New York, NY, Marcel Dekker
    • Ernstoff MS: Combination cytokine therapy in cancer, in Goldfarb RH, Whiteside TL (eds): Tumor Immunology and Cancer Therapy. New York, NY, Marcel Dekker, 1994, pp 273-279
    • (1994) Tumor Immunology and Cancer Therapy , pp. 273-279
    • Ernstoff, M.S.1
  • 8
    • 0242575283 scopus 로고    scopus 로고
    • Tumor immunity meets autoimmunity: Antigen levels and dendritic cell maturation
    • Spiotto MT, Fu YX, Schreiber H: Tumor immunity meets autoimmunity: Antigen levels and dendritic cell maturation. Curr Opin Immunol 15:725-730, 2003
    • (2003) Curr Opin Immunol , vol.15 , pp. 725-730
    • Spiotto, M.T.1    Fu, Y.X.2    Schreiber, H.3
  • 10
    • 24944459890 scopus 로고    scopus 로고
    • Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4
    • Attia P, Phan GQ, Maker AJ, et al: Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol 23:6043-6053, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 6043-6053
    • Attia, P.1    Phan, G.Q.2    Maker, A.J.3
  • 11
    • 0023888654 scopus 로고
    • Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells
    • Atkins MB, Mier JW, Parkinson DR, et al: Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 318:1557-1563, 1988
    • (1988) N Engl J Med , vol.318 , pp. 1557-1563
    • Atkins, M.B.1    Mier, J.W.2    Parkinson, D.R.3
  • 12
    • 0034606276 scopus 로고    scopus 로고
    • Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of t cell-mediated vitiligo
    • Yee C, Thompson JA, Roche P, et al: Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of t cell-mediated vitiligo. J Exp Med 192:1637-1644, 2000
    • (2000) J Exp Med , vol.192 , pp. 1637-1644
    • Yee, C.1    Thompson, J.A.2    Roche, P.3
  • 13
    • 0031890206 scopus 로고    scopus 로고
    • Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
    • Rosenberg SA, Yang JC, Schwartzentruber DJ, et al: Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 4:321-327, 1998
    • (1998) Nat Med , vol.4 , pp. 321-327
    • Rosenberg, S.A.1    Yang, J.C.2    Schwartzentruber, D.J.3
  • 14
    • 0032523943 scopus 로고    scopus 로고
    • Expression of Fas(APO-1/CD95) in tumor infiltrating and peripheral blood lymphocytes in patients with renal call carcinoma
    • Cardi G, Heaney JA, Schned AR: Expression of Fas(APO-1/CD95) in tumor infiltrating and peripheral blood lymphocytes in patients with renal call carcinoma. Cancer Res 58:2078-2080, 1998
    • (1998) Cancer Res , vol.58 , pp. 2078-2080
    • Cardi, G.1    Heaney, J.A.2    Schned, A.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.